Should ECMO be used in cardiogenic shock?

A recent meta-analysis included 3997 patients, with 1696 (42%) receiving a concomitant left ventricular unloading strategy while on VA-ECMO (intra-aortic balloon pump 91.7%, percutaneous ventricular assist device 5.5%, and pulmonary vein or transseptal left atrial cannulation 2.8%). A device such as...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) England), 2019-05, Vol.23 (1), p.174-174, Article 174
Main Authors: Gokalp, Orhan, Donmez, Koksal, Iner, Hasan, Gokalp, Gamze, Besir, Yuksel, Yesilkaya, Nihan Karakas, Yilik, Levent, Gurbuz, Ali
Format: Article
Language:English
Subjects:
Cardiac patients
Cardiogenic shock
Care and treatment
Critical care
Extracorporeal Membrane Oxygenation
Heart attacks
Hospital Mortality
Humans
Intensive care
Letter
Methods
Mortality
Patients
Respiratory therapy
Retrospective Studies
Shock
Shock, Cardiogenic
Technology application
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A recent meta-analysis included 3997 patients, with 1696 (42%) receiving a concomitant left ventricular unloading strategy while on VA-ECMO (intra-aortic balloon pump 91.7%, percutaneous ventricular assist device 5.5%, and pulmonary vein or transseptal left atrial cannulation 2.8%). A device such as IMPELLA might be the best option to decrease afterload and should be inserted concomitantly (ECMELLA). [...]as recently published, a standardized team-based approach may improve CS outcomes, increasing significantly 30-day survival from 47 to 76.6% [8]. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock.
ISSN:1364-8535
1466-609X
1364-8535
1366-609X
DOI:10.1186/s13054-019-2453-2